Cero Terapeutics Hldg Inc (CERO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,304 | -8,976 | -4,748 | -2,300 | -7,290 |
| Depreciation Amortization | 1,162 | 881 | 580 | 286 | 1,117 |
| Accounts payable and accrued liabilities | 259 | -232 | -551 | -287 | 1,281 |
| Other Working Capital | 1,837 | 599 | -329 | -905 | 540 |
| Other Operating Activity | -7,869 | -3,647 | -3,569 | -1,875 | -1,438 |
| Operating Cash Flow | $-12,916 | $-11,376 | $-8,617 | $-5,080 | $-5,790 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 408 | 408 | 408 | 408 | N/A |
| Debt Issued | N/A | N/A | N/A | N/A | 605 |
| Debt Repayment | -20 | -20 | -20 | -20 | -41 |
| Common Stock Issued | N/A | 14 | N/A | N/A | 8 |
| Other Financing Activity | 13,339 | 11,839 | 9,361 | 6,769 | 0 |
| Financing Cash Flow | $13,728 | $12,241 | $9,749 | $7,158 | $572 |
| Beginning Cash Position | 3,479 | 3,479 | 3,479 | 3,479 | 6,820 |
| End Cash Position | 4,291 | 4,344 | 4,611 | 5,557 | 1,601 |
| Net Cash Flow | $812 | $865 | $1,132 | $2,078 | $-5,218 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,916 | -11,376 | -8,617 | -5,080 | -5,790 |
| Free Cash Flow | -12,916 | -11,376 | -8,617 | -5,080 | -5,790 |